A series of dehydroepiandrosterone derivatives containing dihydrazone unit was synthesized via a convenient condensation
procedure, and which were evaluated for their potential anticancer activities. The preliminary assays indicated that some of the newly
synthesized compounds exhibited good antitumor activities against human hepatocellular liver carcinoma (HepG2), heptoma (Huh-7),
gastric cancer (BGC-823) and breast adenocarcinoma (MCF-7) cell lines compared with 5-fluorouracil (5-FU), which might be
considered as promising lead scaffold for further design and synthesis of potential anticancer agents.